Hemopericardium in a Sirolimus-Treated Renal Transplant Patient

被引：0
|
作者：
Groudan, Kevin [1 ]
Sawalha, Khalid [2 ]
Bhat, Anusha G. [1 ]
Eltanbedawi, Ahmed [1 ]
Ambesh, Paurush [3 ]
机构：
[1] Baystate Med Ctr, Internal Med, Springfield, MA 01199 USA
[2] Univ Massachusetts, Med Sch Baystate, Internal Med, Springfield, MA USA
[3] Univ Massachusetts, Med Sch Baystate, Cardiovasc Med, Springfield, MA USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2020年 / 12卷 / 08期
关键词：
hemopericardium; sirolimus; renal transplant; immunosuppression; LYMPHEDEMA;
D O I：
10.7759/cureus.9508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sirolimus is an immunosuppressant frequently prescribed to prevent graft-vs-host disease in renal transplant patients. Pericardial effusion is recognized as a rare and potentially lethal side effect of this medication. Hemopericardium, specifically, is an even rarer complication that has yet to be reported in the literature. We report the first case of sirolimus-induced hemopericardium in a renal transplant patient.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Predictors of proteinuria in renal transplant recipients treated with sirolimus
    Rao, Vinaya
    Miles, Clifford D.
    Sandoz, John
    Henning, Megan E.
    Rigley, Theodore H.
    Nielsen, Kathleen J.
    Stevens, R. Brian
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 586 - 587
  • [22] Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin)
    Brattström, C
    Wilczek, H
    Tydén, G
    Böttiger, Y
    Säwe, J
    Groth, CG
    TRANSPLANTATION, 1998, 65 (09) : 1272 - 1274
  • [23] Successful resolution of inflammation and increased regulatory T cells in sirolimus-treated post-transplant allograft hepatitis
    Ekong, Udeme D.
    Mathew, James
    Melin-Aldana, Hector
    Wang, Deli
    Alonso, Estella M.
    PEDIATRIC TRANSPLANTATION, 2012, 16 (02) : 165 - 175
  • [24] Factors associated with proteinuria in renal transplant recipients treated with sirolimus
    Liew, Adrian
    Chiang, Gilbert S. C.
    Vathsala, Anantharaman
    TRANSPLANT INTERNATIONAL, 2009, 22 (03) : 313 - 322
  • [25] Renal function improves significantly after early cyclosporine withdrawal in sirolimus-treated renal transplant recipients: 3-year results of the Rapamune Maintenance Regimen (RMR) trial.
    Oberbauer, R
    Kreis, H
    Campistol, JM
    Mota, A
    Daloze, P
    Ruiz, JC
    Hartmann, A
    Grinyo, JM
    Chapman, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 10A - 10A
  • [26] Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus
    Campistol, JM
    Holt, DW
    Epstein, S
    Gioud-Paquet, M
    Rutault, K
    Burke, JT
    TRANSPLANT INTERNATIONAL, 2005, 18 (09) : 1028 - 1035
  • [27] Hemopericardium in a Patient Treated with Dabigatran Etexilate
    Barton, Cassie A.
    McMillian, Wesley D.
    Raza, S. Sadi
    Keller, Ray E.
    PHARMACOTHERAPY, 2012, 32 (05): : E103 - E107
  • [28] Sirolimus-associated interstitial pneumonitis in a renal transplant patient
    Bauer, C
    Lidove, O
    Lamotte, C
    Petit, T
    Lieberherr, D
    Chauveheid, MP
    Legendre, C
    Crestani, B
    Dombret, MC
    Laissy, JP
    Antoine, C
    Pegaz-Fiornet, B
    Papo, T
    REVUE DE MEDECINE INTERNE, 2006, 27 (03): : 248 - 252
  • [29] SIROLIMUS ASSOCIATED INTERSTITIAL PNEUMONITIS IN A RENAL TRANSPLANT PATIENT: IS ITAHYPERSENSITIVITY RESPONSE?
    Caliskan, Yasar
    Ecder, Sabahat Alisir
    Guven, Dilek
    Ozkan, Oktay
    Ecder, Tevfik
    Turkmen, Aydin
    Sever, Mehmet Sukru
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2007, 70 (01): : 19 - 22
  • [30] Acute renal failure in a liver transplant patient after treatment with sirolimus
    Pintavorn, P
    Cook, WJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : 692 - 696
12345